Autism and EMF? Plausibility of a pathophysiological link - Part I

Pathophysiology

Volumn 20, Issue 3, 2013, Pages 191-209

  Herbert, Martha R ^a   Sage, Cindy ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Sage Associates Inc   (United States)

Author keywords

Autism; Cellular stress; Children; EMF RFR; Environment; Fetus; Mitochondrial dysfunction; Oscillatory synchronization; Oxidative stress; Radiofrequency; Wireless

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; HEAT SHOCK PROTEIN;

ARTICLE; AUTISM; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CALCIUM CELL LEVEL; CELL MEMBRANE; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; ELECTROMAGNETIC FIELD; ENVIRONMENTAL EXPOSURE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTOXICITY; GERM LINE; GONAD; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RADIATION EXPOSURE; REPRODUCTIVE HEALTH;

EID: 84886095468     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2013.08.001     Document Type: Article

References (298)

1. Blank M. Electromagnetic Fields 2009, Pathophysiology. O. Hanninen (Ed.).
2. The BioInitiative Report 2012 2012, A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF), http://www.bioinitiative.org/. C. Sage, D.O. Carpenter (Eds.).
3. International Commission for Electromagnetic Safety (ICEMS) Non-thermal effects and mechanisms of interaction between electromagnetic fields and living matter. Eur. J. Oncol. Libr. 2010, 5.
4. Interphone Study Group Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int. J. Epidemiol. 2010, 39:675-694.
5. Baan R., Grosse Y., Lauby-Secretan B., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Islami F., Galichet L., Straif K. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol. 2011, 12:624-626.
6. N.R.C.Committee on Identification of Research Needs Relating to Potential Biological or Adverse Health Effects of Wireless Communications Devices Identification of Research Needs Relating to Potential Biological or Adverse Health Effects of Wireless Communication 2008.
7. Herbert M.R., Sage C. Findings in Autism Spectrum Disorders consistent with Electromagnetic Frequencies (EMF) and Radiofrequency Radiation (RFR) 2012, BioInitiative Update, www.BioInitiative.org. C. Sage, D.O. Carpenter (Eds.).
8. Kanner L. Autistic disturbances of affective contact. Nerv. Child 1943, 2:217-250. (reprint in Acta Paedopsychiatr. 35 (4) (1968) 100-136. PMID 4880460).
9. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision), American Psychiatric Publishing, Arlington, VA, 2000.
10. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders DSM-v, American Psychiatric Publishing, Arlington, VA, 2013, May.
11. Herbert M.R. Autism: a brain disorder or a disorder that affects the brain?. Clin. Neuropsychiatry 2005, 2:354-379. http://www.marthaherbert.com/publications.
12. Rapin I., Katzman R. Neurobiology of autism. Ann. Neurol. 1998, 43:7-14.
13. Polleux F., Lauder J.M. Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:303-317.
14. Ming X., Stein T.P., Barnes V., Rhodes N., Guo L. Metabolic perturbance in autism spectrum disorders: a metabolomics study. J. Proteome Res. 2012, 11:5856-5862.
15. Tsaluchidu S., Cocchi M., Tonello L., Puri B.K. Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 2008, 8(Suppl. 1):S5.
16. Pieczenik S.R., Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol. 2007, 83:84-92.
17. Gonzalez A., Stombaugh J., Lozupone C., Turnbaugh P.J., Gordon J.I., Knight R. The mind-body-microbial continuum. Dialogues Clin. Neurosci. 2011, 13:55-62.
18. Nikolov R.N., Bearss K.E., Lettinga J., Erickson C., Rodowski M., Aman M.G., McCracken J.T., McDougle C.J., Tierney E., Vitiello B., Arnold L.E., Shah B., Posey D.J., Ritz L., Scahill L. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J. Autism Dev. Disord. 2009, 39:405-413.
19. Kotagal S., Broomall E. Sleep in children with autism spectrum disorder. Pediatr. Neurol. 2012, 47:242-251.
20. Kaartinen M., Puura K., Makela T., Rannisto M., Lemponen R., Helminen M., Salmelin R., Himanen S.L., Hietanen J.K. Autonomic arousal to direct gaze correlates with social impairments among children with ASD. J. Autism Dev. Disord. 2012, 42:1917-1927.
21. Daluwatte C., Miles J.H., Christ S.E., Beversdorf D.Q., Takahashi T.N., Yao G. Atypical pupillary light reflex and heart rate variability in children with autism spectrum disorder. J. Autism Dev. Disord. 2013, 43:1910-1925.
22. Tuchman R., Cuccaro M. Epilepsy and autism: neurodevelopmental perspective. Curr. Neurol. Neurosci. Rep. 2011, 11:428-434.
23. Canitano R. Epilepsy in autism spectrum disorders. Eur. Child Adolesc. Psychiatry 2007, 16:61-66.
24. Malow B.A. Sleep disorders, epilepsy, and autism. Ment. Retard. Dev. Disabil. Res. Rev. 2004, 10:122-125.
25. Kang J.Q., Barnes G. A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA(A) receptors. J. Autism Dev. Disord. 2013, 43:68-79.
26. Jyonouchi H., Geng L., Streck D.L., Toruner G.A. Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes. J. Neuroimmunol. 2011, 238:73-80.
27. Kohane I.S., McMurry A., Weber G., Macfadden D., Rappaport L., Kunkel L., Bickel J., Wattanasin N., Spence S., Murphy S., Churchill S. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS ONE 2012, 7:e33224.
28. Trikalinos T.A., Karvouni A., Zintzaras E., Ylisaukko-oja T., Peltonen L., Jarvela I., Ioannidis J.P. A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol. Psychiatry 2006, 11:29-36.
29. Ring H., Woodbury-Smith M., Watson P., Wheelwright S., Baron-Cohen S. Clinical heterogeneity among people with high functioning autism spectrum conditions: evidence favouring a continuous severity gradient. Behav. Brain Funct. 2008, 4:11.
30. Pelphrey K.A., Shultz S., Hudac C.M., Vander Wyk B.C. Research review: constraining heterogeneity: the social brain and its development in autism spectrum disorder. J. Child Psychol. Psychiatry 2011, 52:631-644.
31. Mandell D. The heterogeneity in clinical presentation among individuals on the autism spectrum is a remarkably puzzling facet of this set of disorders. Autism 2011, 15:259-261.
32. Hall D., Huerta M.F., McAuliffe M.J., Farber G.K. Sharing heterogeneous data: the national database for autism research. Neuroinformatics 2012, 10:331-339.
33. Bill B.R., Geschwind D.H. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr. Opin. Genet. Dev. 2009, 19:271-278.
34. Whitehouse A.J., Holt B.J., Serralha M., Holt P.G., Hart P.H., Kusel M.M. Maternal vitamin D levels and the autism phenotype among offspring. J. Autism Dev. Disord. 2013, 43:1495-1504.
35. Kocovska E., Fernell E., Billstedt E., Minnis H., Gillberg C. Vitamin D and autism: clinical review. Res. Dev. Disabil. 2012, 33:1541-1550.
36. Schmidt R.J., Hansen R.L., Hartiala J., Allayee H., Schmidt L.C., Tancredi D.J., Tassone F., Hertz-Picciotto I. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 2011, 22:476-485.
37. Landrigan P.J. What causes autism? Exploring the environmental contribution. Curr. Opin. Pediatr. 2010, 22:219-225.
38. Roberts E.M., English P.B., Grether J.K., Windham G.C., Somberg L., Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ. Health Perspect. 2007 Oct, 115(10):1482-1489.
39. Shelton J.F., Hertz-Picciotto I., Pessah I.N. Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ. Health Perspect. 2012, 120:944-951.
40. Becerra T.A., Wilhelm M., Olsen J., Cockburn M., Ritz B. Ambient air pollution and autism in Los Angeles County, California. Environ. Health Perspect. 2013, 121:380-386.
41. Volk H.E., Hertz-Picciotto I., Delwiche L., Lurmann F., McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ. Health Perspect. 2011, 119:873-877.
42. Bilbo S.D., Jones J.P., Parker W. Is autism a member of a family of diseases resulting from genetic/cultural mismatches? Implications for treatment and prevention. Autism Res. Treat. 2012, 2012:910946.
43. Knox S.S. From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer. Cancer Cell Int. 2010, 10:11.
44. Herbert M.R. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr. Opin. Neurol. 2010, 23:103-110.
45. Wei H., Chadman K.K., McCloskey D.P., Sheikh A.M., Malik M., Brown W.T., Li X. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. Biochim. Biophys. Acta 2012, 1822:831-842.
46. Careaga M., Ashwood P. Autism spectrum disorders: from immunity to behavior. Methods Mol. Biol. 2012, 934:219-240.
47. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
48. Heuer L., Ashwood P., Schauer J., Goines P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008, 1:275-283.
49. Zerrate M.C., Pletnikov M., Connors S.L., Vargas D.L., Seidler F.J., Zimmerman A.W., Slotkin T.A., Pardo C.A. Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J. Pharmacol. Exp. Ther. 2007, 322:16-22.
50. Curran L.K., Newschaffer C.J., Lee L.C., Crawford S.O., Johnston M.V., Zimmerman A.W. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007, 120:e1386-e1392.
51. Helt M., Kelley E., Kinsbourne M., Pandey J., Boorstein H., Herbert M., Fein D. Can children with autism recover? If so, how?. Neuropsychol. Rev. 2008, 18:339-366.
52. Cobb S., Guy J., Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochem. Soc. Trans. 2010, 38:498-506.
53. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., Ramesh V., Silva A.J. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat. Med. 2008, 14:843-848.
54. Goebel-Goody S.M., Wilson-Wallis E.D., Royston S., Tagliatela S.M., Naegele J.R., Lombroso P.J. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Genes Brain Behav. 2012, 11:586-600.
55. Henderson C., Wijetunge L., Kinoshita M.N., Shumway M., Hammond R.S., Postma F.R., Brynczka C., Rush R., Thomas A., Paylor R., Warren S.T., Vanderklish P.W., Kind P.C., Carpenter R.L., Bear M.F., Healy A.M. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABA(B) receptors with arbaclofen. Sci. Transl. Med. 2012, 4:152ra128.
56. Kaphzan H., Hernandez P., Jung J.I., Cowansage K.K., Deinhardt K., Chao M.V., Abel T., Klann E. Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors. Biol. Psychiatry 2012, 72:182-190.
57. Liu Z.H., Huang T., Smith C.B. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome. Neurobiol. Dis. 2012, 45:1145-1152.
58. Mehta M.V., Gandal M.J., Siegel S.J. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS ONE 2011, 6:e26077.
59. Paylor R., Yuva-Paylor L.A., Nelson D.L., Spencer C.M. Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene. Behav. Neurosci. 2008, 122:1371-1377.
60. Rotschafer S.E., Trujillo M.S., Dansie L.E., Ethell I.M., Razak K.A. Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome. Brain Res. 2012, 1439:7-14.
61. Sato A., Kasai S., Kobayashi T., Takamatsu Y., Hino O., Ikeda K., Mizuguchi M. Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat. Commun. 2012, 3:1292.
62. Suvrathan A., Hoeffer C.A., Wong H., Klann E., Chattarji S. Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11591-11596.
63. Narayanan A., White C.A., Saklayen S., Scaduto M.J., Carpenter A.L., Abduljalil A., Schmalbrock P., Beversdorf D.Q. Effect of propranolol on functional connectivity in autism spectrum disorder - a pilot study. Brain Imaging Behav. 2010, 4:189-197.
64. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Vaisanen M.L., Nelson M.N., Wexler H.M. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 2000, 15:429-435.
65. Herbert M.R. Autism: The Centrality of Active Pathophysiology and the Shift from Static to Chronic Dynamic Encephalopathy 2009, Taylor & Francis/CRC Press.
66. Edelson M.E. Are the majority of children with autism mentally retarded? A systematic evaluation of the data. Focus Autism Other Dev. Disabil. 2006, 21:66-82.
67. Dawson M., Soulieres I., Gernsbacher M.A., Mottron L. The level and nature of autistic intelligence. Psychol. Sci. 2007, 18:657-662.
68. Soulieres I., Zeffiro T.A., Girard M.L., Mottron L. Enhanced mental image mapping in autism. Neuropsychologia 2011, 49:848-857.
69. Soulieres I., Dawson M., Gernsbacher M.A., Mottron L. The level and nature of autistic intelligence II: what about Asperger syndrome?. PLoS ONE 2011, 6:e25372.
70. Samson F., Mottron L., Soulieres I., Zeffiro T.A. Enhanced visual functioning in autism: an ALE meta-analysis. Hum. Brain Mapp. 2012, 33:1553-1581.
71. Soulieres I., Hubert B., Rouleau N., Gagnon L., Tremblay P., Seron X., Mottron L. Superior estimation abilities in two autistic spectrum children. Cogn. Neuropsychol. 2010, 27:261-276.
72. Soulieres I., Dawson M., Samson F., Barbeau E.B., Sahyoun C.P., Strangman G.E., Zeffiro T.A., Mottron L. Enhanced visual processing contributes to matrix reasoning in autism. Hum. Brain Mapp. 2009, 30:4082-4107.
73. Mottron L., Dawson M., Soulieres I., Hubert B., Burack J. Enhanced perceptual functioning in autism: an update, and eight principles of autistic perception. J. Autism Dev. Disord. 2006, 36:27-43.
74. Mottron L. Matching strategies in cognitive research with individuals with high-functioning autism: current practices, instrument biases, and recommendations. J. Autism Dev. Disord. 2004, 34:19-27.
75. Bertone A., Mottron L., Jelenic P., Faubert J. Enhanced and diminished visuo-spatial information processing in autism depends on stimulus complexity. Brain 2005, 128:2430-2441.
76. Perreault A., Gurnsey R., Dawson M., Mottron L., Bertone A. Increased sensitivity to mirror symmetry in autism. PLoS ONE 2011, 6:e19519.
77. Korson M. Intermittent autism in patients with mitochondrial disease. Autism: Genes, Brains, Babies and Beyond 2007, Massachusetts General Hospital.
78. Herbert M.R., Weintraub K. The Autism Revolution: Whole Body Strategies for Making Life All It Can Be 2012, Random House with Harvard Health Publications, New York, NY.
79. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N. Y. Acad. Sci. 1998, 840:33-44.
80. Juutilainen J., Kumlin T., Naarala J. Do extremely low frequency magnetic fields enhance the effects of environmental carcinogens? A meta-analysis of experimental studies. Int. J. Radiat. Biol. 2006, 82:1-12.
81. Sage C., Carpenter D. Key scientific evidence and public health policy recommendations. The BioInitiative Report 2012: A Rationale for a Biologically-Based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, http://www.bioinitiative.org/table-of-contents/.
82. Lintas C., Sacco R., Persico A.M. Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol. Dis. 2012, 45:57-68.
83. Kong S.W., Collins C.D., Shimizu-Motohashi Y., Holm I.A., Campbell M.G., Lee I.H., Brewster S.J., Hanson E., Harris H.K., Lowe K.R., Saada A., Mora A., Madison K., Hundley R., Egan J., McCarthy J., Eran A., Galdzicki M., Rappaport L., Kunkel L.M., Kohane I.S. Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS ONE 2012, 7:e49475.
84. Jung J.Y., Kohane I.S., Wall D.P. Identification of autoimmune gene signatures in autism. Transl. Psychiatry 2011, 1:e63.
85. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
86. Waly M.I., Hornig M., Trivedi M., Hodgson N., Kini R., Ohta A., Deth R. Prenatal and postnatal epigenetic programming: implications for Gi, immune, and neuronal function in autism. Autism Res. Treat. 2012, 2012:190930.
87. Kanthasamy A., Jin H., Anantharam V., Sondarva G., Rangasamy V., Rana A. Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration. Neurotoxicology 2012, 33:833-837.
88. Roberts R.A., Smith R.A., Safe S., Szabo C., Tjalkens R.B., Robertson F.M. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology 2010, 276:85-94.
89. Rose S., Melnyk S., Trusty T.A., Pavliv O., Seidel L., Li J., Nick T., James S.J. Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Res. Treat. 2012, 2012:986519.
90. Rose S., Melnyk S., Pavliv O., Bai S., Nick T.G., Frye R.E., James S.J. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl. Psychiatry 2012, 2:e134.
91. Ghanizadeh A., Akhondzadeh S., Hormozi, Makarem A., Abotorabi M., Firoozabadi A. Glutathione-related factors and oxidative stress in autism, a review. Curr. Med. Chem. 2012, 19:4000-4005.
92. Frustaci A., Neri M., Cesario A., Adams J.B., Domenici E., Dalla Bernardina B., Bonassi S. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic. Biol. Med. 2012, 52:2128-2141.
93. Rossignol D.A., Frye R.E. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol. Psychiatry 2012, 17:389-401.
94. Adams J.B., Audhya T., McDonough-Means S., Rubin R.A., Quig D., Geis E., Gehn E., Loresto M., Mitchell J., Atwood S., Barnhouse S., Lee W. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr. Metab. (Lond.) 2011, 8:34.
95. Adams J.B., Audhya T., McDonough-Means S., Rubin R.A., Quig D., Geis E., Gehn E., Loresto M., Mitchell J., Atwood S., Barnhouse S., Lee W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011, 11:111.
96. Mostafa G.A., El-Hadidi E.S., Hewedi D.H., Abdou M.M. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J. Neuroimmunol. 2010, 219:114-118.
97. Zecavati N., Spence S.J. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 2009, 9:129-136.
98. Yao Y., Walsh W.J., McGinnis W.R., Pratico D. Altered vascular phenotype in autism: correlation with oxidative stress. Arch. Neurol. 2006, 63:1161-1164.
99. Naviaux R.K. Oxidative shielding or oxidative stress?. J. Pharmacol. Exp. Ther. 2012, 342:608-618.
100. Chauhan A., Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13:171-181.
101. Chauhan A., Chauhan V., Brown T. Autism: Oxidative Stress, Inflammation and Immune Abnormalities 2009, Taylor & Francis/CRC Press, Boca Raton, FL.
102. Lai H. Evidence for genotoxic effects - RFR and ELF DNA damage (section 6). The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, http://www.bioinitiative.org/table-of-contents/.
103. Lai H. Evidence for genotoxic effects - RFR and ELF DNA damage (section 6). The BioInitiative Report 2012: A Rationale for a Biologically-Based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2007, http://bioinitiative.org/freeaccess/report/index.htm.
104. Phillips J.L., Singh N.P., Lai H. Electromagnetic fields and DNA damage. Pathophysiology 2009, 16:79-88.
105. Lai H., Singh N.P. Magnetic-field-induced DNA strand breaks in brain cells of the rat. Environ. Health Perspect. 2004, 112:687-694.
106. De Iuliis G.N., Newey R.J., King B.V., Aitken R.J. Mobile phone radiation induces reactive oxygen species production and DNA damage in human spermatozoa in vitro. PLoS ONE 2009, 4:e6446.
107. Bristot Silvestrin R., Bambini-Junior V., Galland F., Daniele Bobermim L., Quincozes-Santos A., Torres Abib R., Zanotto C., Batassini C., Brolese G., Goncalves C.A., Riesgo R., Gottfried C. Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus. Brain Res. 2013, 1495:52-60.
108. Brown M.S., Singel D., Hepburn S., Rojas D.C. Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1) H-MRS study. Autism Res. 2013, 6:1-10.
109. Choudhury P.R., Lahiri S., Rajamma U. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol. Biochem. Behav. 2012, 100:841-849.
110. Essa M.M., Braidy N., Vijayan K.R., Subash S., Guillemin G.J. Excitotoxicity in the pathogenesis of autism. Neurotox. Res. 2013, 23:393-400.
111. Oberman L.M. mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders. Expert Opin. Investig. Drugs 2012, 21:1819-1825.
112. Yang Y., Pan C. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study. Life Sci. 2013, 92:149-153.
113. Chauhan A., Audhya T., Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem. Res. 2012, 37:1681-1689.
114. Main P.A., Angley M.T., O'Doherty C.E., Thomas P., Fenech M. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr. Metab. (Lond.) 2012, 9:35.
115. Pecorelli A., Leoncini S., De Felice C., Signorini C., Cerrone C., Valacchi G., Ciccoli L., Hayek J. Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism. Brain Dev. 2013, 35:146-154.
116. Banerjee A., Garcia-Oscos F., Roychowdhury S., Galindo L.C., Hall S., Kilgard M.P., Atzori M. Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. Int. J. Neuropsychopharmacol. 2012, 1-10.
117. Coghlan S., Horder J., Inkster B., Mendez M.A., Murphy D.G., Nutt D.J. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci. Biobehav. Rev. 2012, 36:2044-2055.
118. Enticott P.G., Kennedy H.A., Rinehart N.J., Tonge B.J., Bradshaw J.L., Fitzgerald P.B. GABAergic activity in autism spectrum disorders: an investigation of cortical inhibition via transcranial magnetic stimulation. Neuropharmacology 2013, 68:202-209.
119. Mendez M.A., Horder J., Myers J., Coghlan S., Stokes P., Erritzoe D., Howes O., Lingford-Hughes A., Murphy D., Nutt D. The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology 2013, 68:195-201.
120. Piton A., Jouan L., Rochefort D., Dobrzeniecka S., Lachapelle K., Dion P.A., Gauthier J., Rouleau G.A. Analysis of the effects of rare variants on splicing identifies alterations in GABA(A) receptor genes in autism spectrum disorder individuals. Eur. J. Hum. Genet. EJHG 2013, 21:749-756.
121. Anitha A., Nakamura K., Thanseem I., Matsuzaki H., Miyachi T., Tsujii M., Iwata Y., Suzuki K., Sugiyama T., Mori N. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 2013, 23:294-302.
122. Anitha A., Nakamura K., Thanseem I., Yamada K., Iwayama Y., Toyota T., Matsuzaki H., Miyachi T., Yamada S., Tsujii M., Tsuchiya K.J., Matsumoto K., Iwata Y., Suzuki K., Ichikawa H., Sugiyama T., Yoshikawa T., Mori N. Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol. Autism 2012, 3:12.
123. Gargus J., Faiqa I. Mitochondrial energy-deficient endophenotype in autism. Am. J. Biochem. Biotechnol. 2008, 4:198-207.
124. Giulivi C., Zhang Y.F., Omanska-Klusek A., Ross-Inta C., Wong S., Hertz-Picciotto I., Tassone F., Pessah I.N. Mitochondrial dysfunction in autism. JAMA 2010, 304:2389-2396.
125. Hadjixenofontos A., Schmidt M.A., Whitehead P.L., Konidari I., Hedges D.J., Wright H.H., Abramson R.K., Menon R., Williams S.M., Cuccaro M.L., Haines J.L., Gilbert J.R., Pericak-Vance M.A., Martin E.R., McCauley J.L. Evaluating mitochondrial DNA variation in autism spectrum disorders. Ann. Hum. Genet. 2013, 77:9-21.
126. Napolioni V., Persico A.M., Porcelli V., Palmieri L. The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: physiological links and abnormalities in autism. Mol. Neurobiol. 2011, 44:83-92.
127. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 2012, 17:290-314.
128. Campisi A., Gulino M., Acquaviva R., Bellia P., Raciti G., Grasso R., Musumeci F., Vanella A., Triglia A. Reactive oxygen species levels and DNA fragmentation on astrocytes in primary culture after acute exposure to low intensity microwave electromagnetic field. Neurosci. Lett. 2010, 473:52-55.
129. Fragopoulou A.F., Samara A., Antonelou M.H., Xanthopoulou A., Papadopoulou A., Vougas K., Koutsogiannopoulou E., Anastasiadou E., Stravopodis D.J., Tsangaris G.T., Margaritis L.H. Brain proteome response following whole body exposure of mice to mobile phone or wireless DECT base radiation. Electromagn. Biol. Med. 2012, 31:250-274.
130. Shapiro M., Akiri G., Chin C., Wisnivesky J.P., Beasley M.B., Weiser T.S., Swanson S.J., Aaronson S.A. Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer. Ann. Surg. 2013, 257:548-554.
131. Ozgur E., Guler G., Seyhan N. Mobile phone radiation-induced free radical damage in the liver is inhibited by the antioxidants N-acetyl cysteine and epigallocatechin-gallate. Int. J. Radiat. Biol. 2010, 86:935-945.
132. Ozguner F., Altinbas A., Ozaydin M., Dogan A., Vural H., Kisioglu A.N., Cesur G., Yildirim N.G. Mobile phone-induced myocardial oxidative stress: protection by a novel antioxidant agent caffeic acid phenethyl ester. Toxicol. Ind. Health 2005, 21:223-230.
133. Moustafa Y.M., Moustafa R.M., Belacy A., Abou-El-Ela S.H., Ali F.M. Effects of acute exposure to the radiofrequency fields of cellular phones on plasma lipid peroxide and antioxidase activities in human erythrocytes. J. Pharm. Biomed. Anal. 2001, 26:605-608.
134. Kesari K.K., Kumar S., Behari J. Effects of radiofrequency electromagnetic wave exposure from cellular phones on the reproductive pattern in male Wistar rats. Appl. Biochem. Biotechnol. 2011, 164:546-559.
135. Jelodar G., Akbari A., Nazifi S. The prophylactic effect of vitamin C on oxidative stress indexes in rat eyes following exposure to radiofrequency wave generated by a BTS antenna model. Int. J. Radiat. Biol. 2013, 89:128-131.
136. Hoyto A., Luukkonen J., Juutilainen J., Naarala J. Proliferation, oxidative stress and cell death in cells exposed to 872MHz radiofrequency radiation and oxidants. Radiat. Res. 2008, 170:235-243.
137. Guney M., Ozguner F., Oral B., Karahan N., Mungan T. 900MHz radiofrequency-induced histopathologic changes and oxidative stress in rat endometrium: protection by vitamins E and C. Toxicol. Ind. Health 2007, 23:411-420.
138. Esmekaya M.A., Ozer C., Seyhan N. 900MHz pulse-modulated radiofrequency radiation induces oxidative stress on heart, lung, testis and liver tissues. Gen. Physiol. Biophys. 2011, 30:84-89.
139. Atasoy H.I., Gunal M.Y., Atasoy P., Elgun S., Bugdayci G. Immunohistopathologic demonstration of deleterious effects on growing rat testes of radiofrequency waves emitted from conventional Wi-Fi devices. J. Pediatr. Urol. 2013, 9:223-229.
140. Al-Demegh M. Rat testicular impairment induced by electromagnetic radiation from a conventional cellular telephone and the protective effects of the antioxidants vitamins C and E. Clinics 2012, 67:785-792.
141. Kumar G. Report on cell tower radiation submitted to Secretary, DOT, Delhi 2010, December, Electrical Engineering Dept, IIT Bombay, Powai, Mumai, gkumar@ee.iitb.ac.in.
142. Meral I., Mert H., Mert N., Deger Y., Yoruk I., Yetkin A., Keskin S. Effects of 900-MHz electromagnetic field emitted from cellular phone on brain oxidative stress and some vitamin levels of guinea pigs. Brain Res. 2007, 1169:120-124.
143. Oktem F., Ozguner F., Mollaoglu H., Koyu A., Uz E. Oxidative damage in the kidney induced by 900-MHz-emitted mobile phone: protection by melatonin. Arch. Med. Res. 2005, 36:350-355.
144. Ozguner F. Protective effects of melatonin and caffeic acid phenethyl ester against retinal oxidative stress in long-term use of mobile phone: a comparative study. Mol. Cell. Biochem. 2006, 282:83-88.
145. Lee D.H., Jacobs D.R., Porta M. Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ. Health Perspect. 2009, 117:1799-1802.
146. Ilhan A., Gurel A., Armutcu F., Kamisli S., Iraz M., Akyol O., Ozen S. Ginkgo biloba prevents mobile phone-induced oxidative stress in rat brain. Clin. Chim. Acta 2004, 340:153-162.
147. Belyaev I. Evidence for disruption by modulation: role of physical and biological variables in bioeffects of non-thermal microwaves for reproducibility, cancer risk and safety standards. BioInitiative 2012: A Rationale for a Biologically-Based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, C. Sage (Ed.).
148. Weisbrot D., Lin H., Ye L., Blank M., Goodman R. Effects of mobile phone radiation on reproduction and development in Drosophila melanogaster. J. Cell. Biochem. 2003, 89:48-55.
149. Velizarov S., Raskmark P., Kwee S. The effects of radiofrequency fields on cell proliferation are non-thermal. Bioelectrochem. Bioenerg. 1999, 48:177-180.
150. Leszczynski D., Nylund R., Joenvaara S., Reivinen J. Applicability of discovery science approach to determine biological effects of mobile phone radiation. Proteomics 2004, 4:426-431.
151. Leszczynski D., Joenvaara S., Reivinen J., Kuokka R. Non-thermal activation of the hsp27/p38MAPK stress pathway by mobile phone radiation in human endothelial cells: molecular mechanism for cancer- and blood-brain barrier-related effects. Differentiation 2002, 70:120-129.
152. de Pomerai D., Daniells C., David H., Allan J., Duce I., Mutwakil M., Thomas D., Sewell P., Tattersall J., Jones D., Candido P. Non-thermal heat-shock response to microwaves. Nature 2000, 405:417-418.
153. Daniells C., Duce I., Thomas D., Sewell P., Tattersall J., de Pomerai D. Transgenic nematodes as biomonitors of microwave-induced stress. Mutat. Res. 1998, 399:55-64.
154. Blank M., Goodman R. Comment: a biological guide for electromagnetic safety: the stress response. Bioelectromagnetics 2004, 25:642-646. discussion 647-648.
155. Padmini E. Physiological adaptations of stressed fish to polluted environments: role of heat shock proteins. Rev. Environ. Contam. Toxicol. 2010, 206:1-27.
156. Bottoni P., Giardina B., Scatena R. Proteomic profiling of heat shock proteins: an emerging molecular approach with direct pathophysiological and clinical implications. Proteomics. Clin. Appl. 2009, 3:636-653.
157. George I., Geddis M.S., Lill Z., Lin H., Gomez T., Blank M., Oz M.C., Goodman R. Myocardial function improved by electromagnetic field induction of stress protein hsp70. J. Cell. Physiol. 2008, 216:816-823.
158. Bohr H., Bohr J. Microwave enhanced kinetics observed in ORD studies of a protein. Bioelectromagnetics 2000, 21:68-72.
159. Mancinelli F., Caraglia M., Abbruzzese A., d'Ambrosio G., Massa R., Bismuto E. Non-thermal effects of electromagnetic fields at mobile phone frequency on the refolding of an intracellular protein: myoglobin. J. Cell. Biochem. 2004, 93:188-196.
160. El-Ansary A., Al-Ayadhi L. Neuroinflammation in autism spectrum disorders. J. Neuroinflamm. 2012, 9:265.
161. Evers M., Cunningham-Rundles C., Hollander E. Heat shock protein 90 antibodies in autism. Mol. Psychiatry 2002, 7(Suppl. 2):S26-S28.
162. El-Ansary A.K., Ben Bacha A., Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J. Neuroinflamm. 2012, 9:74.
163. Walker S.J., Segal J., Aschner M. Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal challenge. Neurotoxicology 2006, 27:685-692.
164. Vojdani A., Bazargan M., Vojdani E., Samadi J., Nourian A.A., Eghbalieh N., Cooper E.L. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin. Diagn. Lab. Immunol. 2004, 11:515-524.
165. Mironova G.D., Baumann M., Kolomytkin O., Krasichkova Z., Berdimuratov A., Sirota T., Virtanen I., Saris N.E. Purification of the channel component of the mitochondrial calcium uniporter and its reconstitution into planar lipid bilayers. J. Bioenerg. Biomembr. 1994, 26:231-238.
166. Liburdy R. Cellular studies and interaction mechanisms of extremely low frequency fields. Radio Sci. 1995, 20:179-203.
167. Ishido M., Nitta H., Kabuto M. Magnetic fields (MF) of 50Hz at 1.2 microT as well as 100 microT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells. Carcinogenesis 2001, 22:1043-1048.
168. Byus C.V., Pieper S.E., Adey W.R. The effects of low-energy 60-Hz environmental electromagnetic fields upon the growth-related enzyme ornithine decarboxylase. Carcinogenesis 1987, 8:1385-1389.
169. Chen G., Upham B.L., Sun W., Chang C.C., Rothwell E.J., Chen K.M., Yamasaki H., Trosko J.E. Effect of electromagnetic field exposure on chemically induced differentiation of friend erythroleukemia cells. Environ. Health Perspect. 2000, 108:967-972.
170. Litovitz T.A., Krause D., Penafiel M., Elson E.C., Mullins J.M. The role of coherence time in the effect of microwaves on ornithine decarboxylase activity. Bioelectromagnetics 1993, 14:395-403.
171. Penafiel L.M., Litovitz T., Krause D., Desta A., Mullins J.M. Role of modulation on the effect of microwaves on ornithine decarboxylase activity in L929 cells. Bioelectromagnetics 1997, 18:132-141.
172. Cain C.D., Thomas D.L., Adey W.R. 60Hz magnetic field acts as co-promoter in focus formation of C3H/10T1/2 cells. Carcinogenesis 1993, 14:955-960.
173. Mevissen M., Haussler M., Loscher W. Alterations in ornithine decarboxylase activity in the rat mammary gland after different periods of 50Hz magnetic field exposure. Bioelectromagnetics 1999, 20:338-346.
174. Adey W.R. Evidence for nonthermal electromagnetic bioeffects: potential health risks in evolving low-frequency & microwave environments. R. College Phys. Lond. 2002, 2002(May):16-17.
175. Desai N.R., Kesari K.K., Agarwal A. Pathophysiology of cell phone radiation: oxidative stress and carcinogenesis with focus on male reproductive system. Reprod. Biol. Endocrinol. 2009, 7:114.
176. Phelan A.M., Lange D.G., Kues H.A., Lutty G.A. Modification of membrane fluidity in melanin-containing cells by low-level microwave radiation. Bioelectromagnetics 1992, 13:131-146.
177. Beneduci A., Filippelli L., Cosentino K., Calabrese M.L., Massa R., Chidichimo G. Microwave induced shift of the main phase transition in phosphatidylcholine membranes. Bioelectrochemistry 2012, 84:18-24.
178. Linz K.W., von Westphalen C., Streckert J., Hansen V., Meyer R. Membrane potential and currents of isolated heart muscle cells exposed to pulsed radio frequency fields. Bioelectromagnetics 1999, 20:497-511.
179. Cammaerts M.C., Debeir O., Cammaerts R. Changes in Paramecium caudatum (protozoa) near a switched-on GSM telephone. Electromagn. Biol. Med. 2011, 30:57-66.
180. El-Ansary A., Al-Daihan S., Al-Dbass A., Al-Ayadhi L. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clin. Biochem. 2010, 43:63-70.
181. Zhang Y., Sun Y., Wang F., Wang Z., Peng Y., Li R. Downregulating the canonical Wnt/beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress. Neurochem. Res. 2012, 37:1409-1419.
182. Al-Gadani Y., El-Ansary A., Attas O., Al-Ayadhi L. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin. Biochem. 2009, 42:1032-1040.
183. Ming X., Stein T.P., Brimacombe M., Johnson W.G., Lambert G.H., Wagner G.C. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:379-384.
184. Zoroglu S.S., Armutcu F., Ozen S., Gurel A., Sivasli E., Yetkin O., Meram I. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254:143-147.
185. Pall M.L. Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects. J. Cell. Mol. Med. 2013, 17:958-965.
186. Nesin V., Bowman A.M., Xiao S., Pakhomov A.G. Cell permeabilization and inhibition of voltage-gated Ca(2+) and Na(+) channel currents by nanosecond pulsed electric field. Bioelectromagnetics 2012, 33:394-404.
187. Maskey D., Kim H.J., Kim H.G., Kim M.J. Calcium-binding proteins and GFAP immunoreactivity alterations in murine hippocampus after 1 month of exposure to 835MHz radiofrequency at SAR values of 1.6 and 4.0W/kg. Neurosci. Lett. 2012, 506:292-296.
188. Maskey D., Kim M., Aryal B., Pradhan J., Choi I.Y., Park K.S., Son T., Hong S.Y., Kim S.B., Kim H.G., Kim M.J. Effect of 835MHz radiofrequency radiation exposure on calcium binding proteins in the hippocampus of the mouse brain. Brain Res. 2010, 1313:232-241.
189. Kittel A., Siklos L., Thuroczy G., Somosy Z. Qualitative enzyme histochemistry and microanalysis reveals changes in ultrastructural distribution of calcium and calcium-activated ATPases after microwave irradiation of the medial habenula. Acta Neuropathol. 1996, 92:362-368.
190. Bawin S.M., Adey W.R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:1999-2003.
191. Blackman C.F., Benane S.G., House D.E., Joines W.T. Effects of ELF (1-120Hz) and modulated (50Hz) RF fields on the efflux of calcium ions from brain tissue in vitro. Bioelectromagnetics 1985, 6:1-11.
192. Blackman C. Induction of calcium efflux from brain tissue by radio frequency radiation. Radio Sci. 1979, 14:93-98.
193. Dutta S.K., Ghosh B., Blackman C.F. Radiofrequency radiation-induced calcium ion efflux enhancement from human and other neuroblastoma cells in culture. Bioelectromagnetics 1989, 10:197-202.
194. Lin-Liu S., Adey W.R. Low frequency amplitude modulated microwave fields change calcium efflux rates from synaptosomes. Bioelectromagnetics 1982, 3:309-322.
195. Byus C.V., Kartun K., Pieper S., Adey W.R. Increased ornithine decarboxylase activity in cultured cells exposed to low energy modulated microwave fields and phorbol ester tumor promoters. Cancer Res. 1988, 48:4222-4226.
196. Adey W. A growing scientific consensus on the cell and molecular biology mediating interactions with EM fields. Symposium on Electromagnetic Transmissions, Health Hazards, Scientific Evidence and Recent Steps in Mitigation 1994.
197. Dutta S.K., Das K., Ghosh B., Blackman C.F. Dose dependence of acetylcholinesterase activity in neuroblastoma cells exposed to modulated radio-frequency electromagnetic radiation. Bioelectromagnetics 1992, 13:317-322.
198. Smith M., Flodman P.L., Gargus J.J., Simon M.T., Verrell K., Haas R., Reiner G.E., Naviaux R., Osann K., Spence M.A., Wallace D.C. Mitochondrial and ion channel gene alterations in autism. Biochim. Biophys. Acta 2012, 1817:1796-1802.
199. 2+ signaling. Curr. Opin. Neurobiol. 2007, 17:112-119.
200. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., Cord B., Palmer T.D., Chikahisa S., Nishino S., Bernstein J.A., Hallmayer J., Geschwind D.H., Dolmetsch R.E. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 2011, 17:1657-1662.
201. Gargus J.J. Mitochondrial component of calcium signaling abnormality in autism. Autism: Oxidative Stress, Inflammation and Immune Abnormalities 2009, 207-224. CRC Press, Boca Raton, FL. A. Chauhan, V. Chauhan, T. Brown (Eds.).
202. Lu A.T., Dai X., Martinez-Agosto J.A., Cantor R.M. Support for calcium channel gene defects in autism spectrum disorders. Mol. Autism 2012, 3:18.
203. Palmieri L., Persico A.M. Mitochondrial dysfunction in autism spectrum disorders: cause or effect?. Biochim. Biophys. Acta 2010, 1797:1130-1137.
204. Peng T.I., Jou M.J. Oxidative stress caused by mitochondrial calcium overload. Ann. N. Y. Acad. Sci. 2010, 1201:183-188.
205. Pessah I.N., Lein P.J. Evidence for Environmental Susceptibility in Autism: What We Need to Know About Gene×Environment Interactions 2008, Humana.
206. Wayman G.A., Bose D.D., Yang D., Lesiak A., Bruun D., Impey S., Ledoux V., Pessah I.N., Lein P.J. PCB-95 modulates the calcium-dependent signaling pathway responsible for activity-dependent dendritic growth. Environ. Health Perspect. 2012, 120:1003-1009.
207. Wayman G.A., Yang D., Bose D.D., Lesiak A., Ledoux V., Bruun D., Pessah I.N., Lein P.J. PCB-95 promotes dendritic growth via ryanodine receptor-dependent mechanisms. Environ. Health Perspect. 2012, 120:997-1002.
208. Stamou M., Streifel K.M., Goines P.E., Lein P.J. Neuronal connectivity as a convergent target of gene-environment interactions that confer risk for autism spectrum disorders. Neurotoxicol. Teratol. 2013, 36:3-16.
209. Cervellati F., Franceschetti G., Lunghi L., Franzellitti S., Valbonesi P., Fabbri E., Biondi C., Vesce F. Effect of high-frequency electromagnetic fields on trophoblastic connexins. Reprod. Toxicol. 2009, 28:59-65.
210. Palfia Z., Somosy Z., Rez G. Tight junctional changes upon microwave and X-ray irradiation. Acta Biol. Hung. 2001, 52:411-416.
211. Fatemi S.H., Folsom T.D., Reutiman T.J., Lee S. Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 2008, 62:501-507.
212. Thomas R.H., Meeking M.M., Mepham J.R., Tichenoff L., Possmayer F., Liu S., MacFabe D.F. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J. Neuroinflamm. 2012, 9:153.
213. Onore C.E., Nordahl C.W., Young G.S., Van de Water J.A., Rogers S.J., Ashwood P. Levels of soluble platelet endothelial cell adhesion molecule-1 and p-selectin are decreased in children with autism spectrum disorder. Biol. Psychiatry 2012, 72:1020-1025.
214. Salford L.G., Nittby H., Persson B.R. Effects of EMF from wireless communication upon the blood-brain barrier. BioInitiative 2012: A Rationale for a Biologically-Based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, C. Sage (Ed.).
215. Somosy Z., Thuroczy G., Kovacs J. Effects of modulated and continuous microwave irradiation on pyroantimonate precipitable calcium content in junctional complex of mouse small intestine. Scanning Microsc. 1993, 7:1255-1261.
216. Salford L.G., Brun A., Sturesson K., Eberhardt J.L., Persson B.R. Permeability of the blood-brain barrier induced by 915MHz electromagnetic radiation, continuous wave and modulated at 8, 16, 50, and 200Hz. Microsc. Res. Tech. 1994, 27:535-542.
217. Salford L.G., Brun A.E., Eberhardt J.L., Malmgren L., Persson B.R. Nerve cell damage in mammalian brain after exposure to microwaves from GSM mobile phones. Environ. Health Perspect. 2003, 111:881-883. discussion A408.
218. Salford L.G., Brun A., Grafstrom G., Eberhardt J., Malmgren L., Persson B. Non-thermal effects of EMF upon the mammalian brain: the Lund experience. Environmentalist 2007, 493-500.
219. Salford L.G., Eberhardt J., Malmgren L., Perrson B. Electromagnetic field-induced permeability of the blood-brain barrier shown by immunohistochemical methods. Interaction Mechanism of Low-Level Electromagnetic Fields, Living Systems 1992, 251-258. Oxford University Press, Oxford.
220. Eberhardt J.L., Persson B.R., Brun A.E., Salford L.G., Malmgren L.O. Blood-brain barrier permeability and nerve cell damage in rat brain 14 and 28 days after exposure to microwaves from GSM mobile phones. Electromagn. Biol. Med. 2008, 27:215-229.
221. Nittby H., Brun A., Eberhardt J., Malmgren L., Persson B.R., Salford L.G. Increased blood-brain barrier permeability in mammalian brain 7 days after exposure to the radiation from a GSM-900 mobile phone. Pathophysiology 2009, 16:103-112.
222. Nittby H., Grafstrom G., Eberhardt J.L., Malmgren L., Brun A., Persson B.R., Salford L.G. Radiofrequency and extremely low-frequency electromagnetic field effects on the blood-brain barrier. Electromagn. Biol. Med. 2008, 27:103-126.
223. Lange D.G., D'Antuono M.E., Timm R.R., Ishii T.K., Fujimoto J.M. Differential response of the permeability of the rat liver canalicular membrane to sucrose and mannitol following in vivo acute single and multiple exposures to microwave radiation (2.45GHz) and radiant-energy thermal stress. Radiat. Res. 1993, 134:54-62.
224. Kues H.A., Monahan J.C., D'Anna S.A., McLeod D.S., Lutty G.A., Koslov S. Increased sensitivity of the non-human primate eye to microwave radiation following ophthalmic drug pretreatment. Bioelectromagnetics 1992, 13:379-393.
225. Parathath S.R., Parathath S., Tsirka S.E. Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J. Cell Sci. 2006, 119:339-349.
226. Hassel B., Iversen E.G., Fonnum F. Neurotoxicity of albumin in vivo. Neurosci. Lett. 1994, 167:29-32.
227. 2+ concentration. Neurosci. Lett. 1991, 130:125-127.
228. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
229. Boso M., Emanuele E., Minoretti P., Arra M., Politi P., Ucelli di Nemi S., Barale F. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism. Neurosci. Lett. 2006, 410:169-173.
230. Young A.M., Campbell E., Lynch S., Suckling J., Powis S.J. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation. Front. Psychiatry 2011, 2:27.
231. Erickson M.A., Dohi K., Banks W.A. Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation 2012, 19:121-130.
232. Janigro D. Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier. Epilepsia 2012, 53(Suppl. 1):26-34.
233. Takeshita Y., Ransohoff R.M. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol. Rev. 2012, 248:228-239.
234. Boddaert N., Zilbovicius M., Philipe A., Robel L., Bourgeois M., Barthelemy C., Seidenwurm D., Meresse I., Laurier L., Desguerre I., Bahi-Buisson N., Brunelle F., Munnich A., Samson Y., Mouren M.C., Chabane N. MRI findings in 77 children with non-syndromic autistic disorder. PLoS ONE 2009, 4:e4415.
235. Vardi N., Freedman N., Lester H., Gomori J.M., Chisin R., Lerer B., Bonne O. Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implications. Psychiatry Res. 2011, 192:125-130.
236. Brickman A.M., Muraskin J., Zimmerman M.E. Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?. Dialogues Clin. Neurosci. 2009, 11:181-190.
237. de Magistris L., Familiari V., Pascotto A., Sapone A., Frolli A., Iardino P., Carteni M., De Rosa M., Francavilla R., Riegler G., Militerni R., Bravaccio C. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 2010, 51:418-424.
238. Lucarelli S., Frediani T., Zingoni A.M., Ferruzzi F., Giardini O., Quintieri F., Barbato M., D'Eufemia P., Cardi E. Food allergy and infantile autism. Panminerva Med. 1995, 37:137-141.
239. D'Eufemia P., Celli M., Finocchiaro R., Pacifico L., Viozzi L., Zaccagnini M., Cardi E., Giardini O. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996, 85:1076-1079.
240. Horvath K., Perman J.A. Autism and gastrointestinal symptoms. Curr. Gastroenterol. Rep. 2002, 4:251-258.
241. White J.F. Intestinal pathophysiology in autism. Exp. Biol. Med. (Maywood) 2003, 228:639-649.
242. Robertson M.A., Sigalet D.L., Holst J.J., Meddings J.B., Wood J., Sharkey K.A. Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study. J. Autism Dev. Disord. 2008, 38:1066-1071.
243. Souza N.C., Mendonca J.N., Portari G.V., Jordao Junior A.A., Marchini J.S., Chiarello P.G. Intestinal permeability and nutritional status in developmental disorders. Altern. Ther. Health Med. 2012, 18:19-24.
244. Silva M.A., Jury J., Sanz Y., Wiepjes M., Huang X., Murray J.A., David C.S., Fasano A., Verdu E.F. Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect. Dig. Dis. Sci. 2012, 57:38-47.
245. Sapone A., Lammers K.M., Casolaro V., Cammarota M., Giuliano M.T., De Rosa M., Stefanile R., Mazzarella G., Tolone C., Russo M.I., Esposito P., Ferraraccio F., Carteni M., Riegler G., de Magistris L., Fasano A. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med. 2011, 9:23.
246. Visser J., Rozing J., Sapone A., Lammers K., Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann. N. Y. Acad. Sci. 2009, 1165:195-205.
247. Simpson M., Mojibian M., Barriga K., Scott F.W., Fasano A., Rewers M., Norris J.M. An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr. Diabetes 2009, 10:563-572.
248. Fasano A. Surprises from celiac disease. Sci. Am. 2009, 301:54-61.
249. Lammers K.M., Lu R., Brownley J., Lu B., Gerard C., Thomas K., Rallabhandi P., Shea-Donohue T., Tamiz A., Alkan S., Netzel-Arnett S., Antalis T., Vogel S.N., Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008, 135:194-204. e193.
250. De Angelis M., Rizzello C.G., Fasano A., Clemente M.G., De Simone C., Silano M., De Vincenzi M., Losito I., Gobbetti M. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue. Biochim. Biophys. Acta 2006, 1762:80-93.
251. Theoharides T.C., Doyle R. Autism, gut-blood-brain barrier, and mast cells. J. Clin. Psychopharmacol. 2008, 28:479-483.
252. Hsiao E.Y., Patterson P.H. Placental regulation of maternal-fetal interactions and brain development. Dev. Neurobiol. 2012, 72:1317-1326.
253. Herbert M. Autism: from static genetic brain defect to dynamic gene-environment modulated pathophysiology. Genetic Explanations: Sense and Nonsense 2013, 122-146. Harvard University Press, Cambridge, MA. S. Krimsky, J. Gruber (Eds.).
254. King M., Bearman P. Diagnostic change and the increased prevalence of autism. Int. J. Epidemiol. 2009, 38:1224-1234.
255. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20:84-90.
256. Anney R., Klei L., Pinto D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Sykes N., Pagnamenta A.T., Almeida J., Bacchelli E., Bailey A.J., Baird G., Battaglia A., Berney T., Bolshakova N., Bolte S., Bolton P.F., Bourgeron T., Brennan S., Brian J., Carson A.R., Casallo G., Casey J., Chu S.H., Cochrane L., Corsello C., Crawford E.L., Crossett A., Dawson G., de Jonge M., Delorme R., Drmic I., Duketis E., Duque F., Estes A., Farrar P., Fernandez B.A., Folstein S.E., Fombonne E., Freitag C.M., Gilbert J., Gillberg C., Glessner J.T., Goldberg J., Green J., Guter S.J., Hakonarson H., Heron E.A., Hill M., Holt R., Howe J.L., Hughes G., Hus V., Igliozzi R., Kim C., Klauck S.M., Kolevzon A., Korvatska O., Kustanovich V., Lajonchere C.M., Lamb J.A., Laskawiec M., Leboyer M., Le Couteur A., Leventhal B.L., Lionel A.C., Liu X.Q., Lord C., Lotspeich L., Lund S.C., Maestrini E., Mahoney W., Mantoulan C., Marshall C.R., McConachie H., McDougle C.J., McGrath J., McMahon W.M., Melhem N.M., Merikangas A., Migita O., Minshew N.J., Mirza G.K., Munson J., Nelson S.F., Noakes C., Noor A., Nygren G., Oliveira G., Papanikolaou K., Parr J.R., Parrini B., Paton T., Pickles A., Piven J., Posey D.J., Poustka A., Poustka F., Prasad A., Ragoussis J., Renshaw K., Rickaby J., Roberts W., Roeder K., Roge B., Rutter M.L., Bierut L.J., Rice J.P., Salt J., Sansom K., Sato D., Segurado R., Senman L., Shah N., Sheffield V.C., Soorya L., Sousa I., Stoppioni V., Strawbridge C., Tancredi R., Tansey K., Thiruvahindrapduram B., Thompson A.P., Thomson S., Tryfon A., Tsiantis J., Van Engeland H., Vincent J.B., Volkmar F., Wallace S., Wang K., Wang Z., Wassink T.H., Wing K., Wittemeyer K., Wood S., Yaspan B.L., Zurawiecki D., Zwaigenbaum L., Betancur C., Buxbaum J.D., Cantor R.M., Cook E.H., Coon H., Cuccaro M.L., Gallagher L., Geschwind D.H., Gill M., Haines J.L., Miller J., Monaco A.P., Nurnberger J.I., Paterson A.D., Pericak-Vance M.A., Schellenberg G.D., Scherer S.W., Sutcliffe J.S., Szatmari P., Vicente A.M., Vieland V.J., Wijsman E.M., Devlin B., Ennis S., Hallmayer J. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 2010, 19:4072-4082.
257. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011, 1380:42-77.
258. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., Lotspeich L., Croen L.A., Ozonoff S., Lajonchere C., Grether J.K., Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 2011, 68:1095-1102.
259. Davis J.O., Phelps J.A., Bracha H.S. Prenatal development of monozygotic twins and concordance for schizophrenia. Schizophr. Bull. 1995, 21:357-366.
260. Kinney D.K., Barch D.H., Chayka B., Napoleon S., Munir K.M. Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder?. Med. Hypotheses 2010, 74:102-106.
261. Ruediger H.W. Genotoxic effects of radiofrequency electromagnetic fields. Pathophysiology 2009, 16:89-102.
262. Ivancsits S., Pilger A., Diem E., Jahn O., Rudiger H.W. Cell type-specific genotoxic effects of intermittent extremely low-frequency electromagnetic fields. Mutat. Res. 2005, 583:184-188.
263. Diem E., Schwarz C., Adlkofer F., Jahn O., Rudiger H. Non-thermal DNA breakage by mobile-phone radiation (1800MHz) in human fibroblasts and in transformed GFSH-R17 rat granulosa cells in vitro. Mutat. Res. 2005, 583:178-183.
264. Blank M., Goodman R. DNA is a fractal antenna in electromagnetic fields. Int. J. Radiat. Biol. 2011, 87:409-415.
265. REFLEX, Final Report, REFLEX (Risk Evaluation of Potential Environmental Hazards From Low-Energy Electromagnetic Field Exposure Using Sensitive in vitro Methods), Key Action 4 "Environment and Health", in: Quality of Life and Management of Living Resources. European Union, 2004, 31 May. http://ec.europa.eu/research/environment/pdf/env_health_projects/electromagnetic_fields/e-reflex.pdf.
266. Sage C., Carpenter D.O. Public health implications of wireless technologies. Pathophysiology 2009, 16:233-246.
267. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., Polak P., Yoon S., Maguire J., Crawford E.L., Campbell N.G., Geller E.T., Valladares O., Schafer C., Liu H., Zhao T., Cai G., Lihm J., Dannenfelser R., Jabado O., Peralta Z., Nagaswamy U., Muzny D., Reid J.G., Newsham I., Wu Y., Lewis L., Han Y., Voight B.F., Lim E., Rossin E., Kirby A., Flannick J., Fromer M., Shakir K., Fennell T., Garimella K., Banks E., Poplin R., Gabriel S., DePristo M., Wimbish J.R., Boone B.E., Levy S.E., Betancur C., Sunyaev S., Boerwinkle E., Buxbaum J.D., Cook E.H., Devlin B., Gibbs R.A., Roeder K., Schellenberg G.D., Sutcliffe J.S., Daly M.J. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
268. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B., Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E., Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
269. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., Walker M.F., Ober G.T., Teran N.A., Song Y., El-Fishawy P., Murtha R.C., Choi M., Overton J.D., Bjornson R.D., Carriero N.J., Meyer K.A., Bilguvar K., Mane S.M., Sestan N., Lifton R.P., Gunel M., Roeder K., Geschwind D.H., Devlin B., State M.W. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
270. Markova E., Hillert L., Malmgren L., Persson B.R., Belyaev I.Y. Microwaves from GSM mobile telephones affect 53BP1 and gamma-H2AX foci in human lymphocytes from hypersensitive and healthy persons. Environ. Health Perspect. 2005, 113:1172-1177.
271. Belyaev I.Y., Hillert L., Protopopova M., Tamm C., Malmgren L.O., Persson B.R., Selivanova G., Harms-Ringdahl M. 915MHz microwaves and 50Hz magnetic field affect chromatin conformation and 53BP1 foci in human lymphocytes from hypersensitive and healthy persons. Bioelectromagnetics 2005, 26:173-184.
272. Markova E., Malmgren L.O.G., Belyaev I. Microwaves from mobile phones inhibit 53BP1 focus formation in human stem cells more strongly than in differentiated cells: possible mechanistic link to cancer risk. Environ. Health Perspect. 2010, 394-399.
273. Christophersen O.A., Haug A. Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacology. Lipids Health Dis. 2011, 10:16.
274. Belyaev I., Alipov Y.D., Harms-Ringdahl M. Effects of zero magnetic field on the conformation of chromatin in human cells. Biochim. Biophys. Acta 1997, 1336:465-473.
275. Belyaev S., Kravchenko V. Resonance effect of low-intensity millimeter waves on the chromatin conformational state of rat thymocytes. Z. Naturforsch. 1994, 49.
276. Paul C., Nagano M., Robaire B. Aging results in differential regulation of DNA repair pathways in pachytene spermatocytes in the Brown Norway rat. Biol. Reprod. 2011, 85:1269-1278.
277. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y.H., Narzisi G., Leotta A., Kendall J., Grabowska E., Ma B., Marks S., Rodgers L., Stepansky A., Troge J., Andrews P., Bekritsky M., Pradhan K., Ghiban E., Kramer M., Parla J., Demeter R., Fulton L.L., Fulton R.S., Magrini V.J., Ye K., Darnell J.C., Darnell R.B., Mardis E.R., Wilson R.K., Schatz M.C., McCombie W.R., Wigler M. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
278. Cantor R.M., Yoon J.L., Furr J., Lajonchere C.M. Paternal age and autism are associated in a family-based sample. Mol. Psychiatry 2007, 12:419-421.
279. Alter M.D., Kharkar R., Ramsey K.E., Craig D.W., Melmed R.D., Grebe T.A., Bay R.C., Ober-Reynolds S., Kirwan J., Jones J.J., Turner J.B., Hen R., Stephan D.A. Autism and increased paternal age related changes in global levels of gene expression regulation. PLoS ONE 2011, 6:e16715.
280. Agarwal A., Deepinder F., Sharma R.K., Ranga G., Li J. Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertil. Steril. 2008, 89:124-128.
281. Agarwal A., Desai N.R., Makker K., Varghese A., Mouradi R., Sabanegh E., Sharma R. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil. Steril. 2009, 92:1318-1325.
282. Wdowiak A., Wdowiak L., Wiktor H. Evaluation of the effect of using mobile phones on male fertility. Ann. Agric. Environ. Med. 2007, 14:169-172.
283. Fejes I., Zavaczki Z., Szollosi J., Koloszar S., Daru J., Kovacs L., Pal A. Is there a relationship between cell phone use and semen quality?. Arch. Androl. 2005, 51:385-393.
284. Aitken R.J., Bennetts L.E., Sawyer D., Wiklendt A.M., King B.V. Impact of radio frequency electromagnetic radiation on DNA integrity in the male germline. Int. J. Androl. 2005, 28:171-179.
285. Erogul O., Oztas E., Yildirim I., Kir T., Aydur E., Komesli G., Irkilata H.C., Irmak M.K., Peker A.F. Effects of electromagnetic radiation from a cellular phone on human sperm motility: an in vitro study. Arch. Med. Res. 2006, 37:840-843.
286. Dasdag S., Ketani M.A., Akdag Z., Ersay A.R., Sari I., Demirtas O.C., Celik M.S. Whole-body microwave exposure emitted by cellular phones and testicular function of rats. Urol. Res. 1999, 27:219-223.
287. Yan J.G., Agresti M., Bruce T., Yan Y.H., Granlund A., Matloub H.S. Effects of cellular phone emissions on sperm motility in rats. Fertil. Steril. 2007, 88:957-964.
288. Otitoloju A.A., Obe I.A., Adewale O.A., Otubanjo O.A., Osunkalu V.O. Preliminary study on the induction of sperm head abnormalities in mice, Mus musculus, exposed to radiofrequency radiations from global system for mobile communication base stations. Bull. Environ. Contam. Toxicol. 2010, 84:51-54.
289. Salama N., Kishimoto T., Kanayama H.O., Kagawa S. The mobile phone decreases fructose but not citrate in rabbit semen: a longitudinal study. Syst. Biol. Reprod. Med. 2009, 55:181-187.
290. Kesari K.K., Kumar S., Nirala J., Siddiqui M.H., Behari J. Biophysical evaluation of radiofrequency electromagnetic field effects on male reproductive pattern. Cell Biochem. Biophys. 2013, 65:85-96.
291. Zalata A.A., Christophe A.B., Depuydt C.E., Schoonjans F., Comhaire F.H. The fatty acid composition of phospholipids of spermatozoa from infertile patients. Mol. Hum. Reprod. 1998, 4:111-118.
292. Zalata A., Hafez T., Comhaire F. Evaluation of the role of reactive oxygen species in male infertility. Hum. Reprod. 1995, 10:1444-1451.
293. Panagopoulos D.J. Effect of microwave exposure on the ovarian development of Drosophila melanogaster. Cell Biochem. Biophys. 2012, 63:121-132.
294. Gul A., Celebi H., Ugras S. The effects of microwave emitted by cellular phones on ovarian follicles in rats. Arch. Gynecol. Obstet. 2009, 280:729-733.
295. Magras I.N., Xenos T.D. RF radiation-induced changes in the prenatal development of mice. Bioelectromagnetics 1997, 18:455-461.
296. Silberman S. The Geek Syndrome 2001, Wired.
297. Derecki N.C., Cronk J.C., Lu Z., Xu E., Abbott S.B., Guyenet P.G., Kipnis J. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012, 484:105-109.
298. Derecki N.C., Cronk J.C., Kipnis J. The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol. 2013, 34:144-150.